GetTopicDetailResponse(id=bd1a33520b2, topicName=化學(xué)藥品, introduction=化學(xué)藥品, content=null, image=null, comments=4, allHits=1525, url=https://h5.medsci.cn/topic?id=33520, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=32646, tagList=[TagDto(tagId=32646, tagName=化學(xué)藥品)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1395258, encodeId=edc0139525893, content=<a href='/topic/show?id=bd1a33520b2' target=_blank style='color:#2F92EE;'>#化學(xué)藥品#</a>, objectTitle=CDE新增14條常見一般性技術(shù)問題解答：化學(xué)藥品仿制藥能否直接申報(bào)上市許可申請？, objectType=article, longId=204181, objectId=dc0720418157, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc0720418157, replyNumber=0, likeNumber=98, createdTime=2020-12-07, rootId=0, userName=ms7405317358118777, userId=f92f2500185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc0720418157, moduleTitle=CDE新增14條常見一般性技術(shù)問題解答：化學(xué)藥品仿制藥能否直接申報(bào)上市許可申請？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dc0720418157)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395257, encodeId=c755139525e9d, content=<a href='/topic/show?id=bd1a33520b2' target=_blank style='color:#2F92EE;'>#化學(xué)藥品#</a>, objectTitle=化學(xué)藥品注射劑仿制藥一致性評價技術(shù)要求征求意見, objectType=article, longId=181345, objectId=f93918134574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f93918134574, replyNumber=0, likeNumber=87, createdTime=2019-10-18, rootId=0, userName=ms7405317358118777, userId=f92f2500185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f93918134574, moduleTitle=化學(xué)藥品注射劑仿制藥一致性評價技術(shù)要求征求意見, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f93918134574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395256, encodeId=4cd21395256c9, content=<a href='/topic/show?id=bd1a33520b2' target=_blank style='color:#2F92EE;'>#化學(xué)藥品#</a>, objectTitle=化學(xué)藥品注冊分類改革方案的13個疑惑, objectType=article, longId=65024, objectId=171365024c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=171365024c0, replyNumber=0, likeNumber=110, createdTime=2016-03-19, rootId=0, userName=ms7405317358118777, userId=f92f2500185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=171365024c0, moduleTitle=化學(xué)藥品注冊分類改革方案的13個疑惑, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=171365024c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395255, encodeId=816d13952554b, content=<a href='/topic/show?id=bd1a33520b2' target=_blank style='color:#2F92EE;'>#化學(xué)藥品#</a>, objectTitle=化學(xué)藥品和治療用生物制品上市后研究報(bào)告格式(征求意見稿), objectType=article, longId=31439, objectId=03993143982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03993143982, replyNumber=0, likeNumber=88, createdTime=2014-03-05, rootId=0, userName=ms7405317358118777, userId=f92f2500185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03993143982, moduleTitle=化學(xué)藥品和治療用生物制品上市后研究報(bào)告格式(征求意見稿), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=03993143982)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
